How do transplant surgeons accomplish optimal portal venous flow during living-donor liver transplantation? noninvasive measurement of indocyanine green elimination rate

Surgical Innovation

Volumn 21, Issue 1, 2014, Pages 43-51

  Hori, Tomohide ^a,b   Ogura, Yasuhiro ^a   Yagi, Shintaro ^a   Iida, Taku ^a   Taniguchi, Kentaro ^c   Moghazy, Walid M El ^a   Hedaya, Mohammed Saied ^a   Segawa, Hajime ^a   Ogawa, Kohei ^a   Kogure, Takayuki ^d   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b MAYO CLINIC   (United States)

^c MIE UNIVERSITY HOSPITAL   (Japan)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

graft recipient body weight ratio; indocyanine green; portal hypertension; portal pressure; small for size

Indexed keywords

INDOCYANINE GREEN; COLORING AGENT;

ADULT; ARTICLE; BLOOD GROUP ABO SYSTEM; CLINICAL ARTICLE; COLD ISCHEMIA; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER BIOPSY; LIVER CELL; LIVER TRANSPLANTATION; LIVING DONOR; MALE; ORGAN WEIGHT; OVERALL SURVIVAL; PATIENT SAFETY; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; SURVIVAL RATE; TRANSPLANT SURGEON; GRAFT SURVIVAL; HEMODYNAMICS; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; NEEDLE BIOPSY; PORTAL VEIN; POSTOPERATIVE COMPLICATION; PROCEDURES; RISK FACTOR; SURGERY;

BIOPSY, NEEDLE; COLORING AGENTS; FEMALE; GRAFT SURVIVAL; HEMODYNAMICS; HUMANS; IMMUNOSUPPRESSION; INDOCYANINE GREEN; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PORTAL PRESSURE; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURVIVAL RATE;

EID: 84900389292     PISSN: 15533506     EISSN: 15533514     Source Type: Journal    
DOI: 10.1177/1553350613487803     Document Type: Article

References (27)

1. Yamaoka Y, Washida M, Honda K, et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation. 1994 ; 57: 1127-1130
2. Inomata Y, Uemoto S, Asonuma K, Egawa H. Right lobe graft in living donor liver transplantation. Transplantation. 2000 ; 69: 258-264
3. Ogura Y, Hori T, El Moghazy WM, et al. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl. 2010 ; 16: 718-728
4. Ogura Y, Hori T, Uemoto S. Intentional portal pressure control is key to improving the outcome of living donor liver transplantation: the Kyoto University Hospital experience. Clin Transpl. 2008 ;: 143-149
5. Yagi S, Iida T, Hori T, et al. Optimal portal venous circulation for liver graft function after living-donor liver transplantation. Transplantation. 2006 ; 81: 373-378
6. Yagi S, Iida T, Taniguchi K, et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl. 2005 ; 11: 68-75
7. Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003 ; 75: 1313-1317
8. Schenk A, Hindennach M, Radtke A, Malago M, Schroeder T, Peitgen HO. Formation of venous collaterals and regeneration in the donor remnant liver: volumetric analysis and three-dimensional visualization. Transplant Proc. 2009 ; 41: 2515-2517
9. Hori T, Yamamoto C, Yagi S, et al. Assessment of cardiac output in liver transplantation recipients. Hepatobiliary Pancreat Dis Int. 2008 ; 7: 362-366
10. Tanaka K, Inomata Y, Kaihara S Living-Donor Liver Transplantation. Barcelona, Spain: Prous Science ; 2003 :
11. Hori T, Ogura Y, Ogawa K, et al. How transplant surgeons can overcome the inevitable insufficiency of allograft size during adult living-donor liver transplantation: strategy for donor safety with a smaller-size graft and excellent recipient results. Clin Transplant. 2012 ; 26: E324 - E334
12. Takada Y, Ito T, Ueda Y, et al. Effects of double-filtration plasmapheresis combined with interferon plus ribavirin for recurrent hepatitis C after living donor liver transplantation. Liver Transpl. 2008 ; 14: 1044-1047
13. Kishi Y, Sugawara Y, Akamatsu N, et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant. 2005 ; 19: 769-772
14. Egawa H, Teramukai S, Haga H, Tanabe M, Fukushima M, Shimazu M. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology. 2008 ; 47: 143-152
15. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994 ; 20: 15-20
16. Iida T, Yagi S, Taniguchi K, et al. Significance of CT attenuation value in liver grafts following right lobe living-donor liver transplantation. Am J Transplant. 2005 ; 5: 1076-1084
17. Onaca NN, Levy MF, Netto GJ, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant. 2003 ; 3: 626-630
18. Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008 ; 8: 2537-2546
19. Ghobrial RM, Steadman R, Gornbein J, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg. 2001 ; 234: 384-393
20. Hori T, Uemoto S, Takada Y, et al. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?. Surgery. 2010 ; 147: 840-844
21. Hori T, Iida T, Yagi S, et al. KICG value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl. 2006 ; 12: 605-613
22. Eguchi S, Yanaga K, Sugiyama N, Okudaira S, Furui J, Kanematsu T. Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation. Liver Transpl. 2003 ; 9: 547-551
23. Hori T, Yagi S, et al. Optimal systemic hemodynamic stability for successful clinical outcomes after adult living-donor liver transplantation: prospective observational study. J Gastroenterol Hepatol. 2008 ; 23: e170 - e178
24. Hori T, Yagi S, et al. Stability of cirrhotic systemic hemodynamics ensures sufficient splanchnic blood flow after living-donor liver transplantation in adult recipients with liver cirrhosis. World J Gastroenterol. 2007 ; 13: 5918-5925
25. Levesque E, Saliba F, Benhamida S, et al. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation. Liver Transpl. 2009 ; 15: 1358-1364
26. Jalan R, Plevris JN, Jalan AR, Finlayson ND, Hayes PC. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation. 1994 ; 58: 196-200
27. Tsubono T, Todo S, Jabbour N, et al. Indocyanine green elimination test in orthotopic liver recipients. Hepatology. 1996 ; 24: 1165-1171